VR
Virpax Pharmaceuticals, Inc.
VRPX · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $124.0
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0
100.0% downside
Trenutna cena
$0.0001
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica VRPX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
0/9Valuation
-
N/A PEG N/A
P/E N/A
P/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
57 /100
Average Asset turnover 0.00x
ROIC 1,322.00%
ROA 775.72%
Debt
6 /100
High Int. coverage -116.10x
Current ratio 0.63x
Debt/Assets N/A
Stability
1 /100
Unstable Profitable years 0
Beta 2.44x
EPS volatility 249.89%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VRPX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jatinder Dhaliwal
Employees
2
Headquarters
Berwyn
Prihajajoči dogodki
19 NOV.
Earnings
Upcoming earnings report